These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8424846)

  • 1. LY248686, a new inhibitor of serotonin and norepinephrine uptake.
    Wong DT; Bymaster FP; Mayle DA; Reid LR; Krushinski JH; Robertson DW
    Neuropsychopharmacology; 1993 Jan; 8(1):23-33. PubMed ID: 8424846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
    Kasamo K; Blier P; De Montigny C
    J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
    Kihara T; Ikeda M
    J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.
    Wong DT; Robertson DW; Bymaster FP; Krushinski JH; Reid LR
    Life Sci; 1988; 43(24):2049-57. PubMed ID: 2850421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
    Katoh A; Eigyo M; Ishibashi C; Naitoh Y; Takeuchi M; Ibii N; Ikeda M; Matsushita A
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1067-75. PubMed ID: 7891317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
    Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
    Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.
    Engleman EA; Robertson DW; Thompson DC; Perry KW; Wong DT
    J Neurochem; 1996 Feb; 66(2):599-603. PubMed ID: 8592129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
    Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
    Rueter LE; De Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
    Huang X; Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1992 Dec; 229(1):31-8. PubMed ID: 1473561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Li XR; Tang Y; Xiong J; Chen HX; Xue R; Li YF
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):544-56. PubMed ID: 25638027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
    Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
    Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.